REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 163 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $259,000 | -37.4% | 10,280 | -34.5% | 0.03% | -43.5% |
| Q4 2021 | $414,000 | +77.7% | 15,700 | +579.7% | 0.05% | +64.3% |
| Q3 2021 | $233,000 | -59.1% | 2,310 | -59.6% | 0.03% | -56.2% |
| Q1 2021 | $570,000 | +125.3% | 5,713 | +252.9% | 0.06% | +68.4% |
| Q2 2020 | $253,000 | -28.1% | 1,619 | -6.0% | 0.04% | -32.1% |
| Q4 2019 | $352,000 | +46.1% | 1,722 | -42.6% | 0.06% | +33.3% |
| Q3 2019 | $241,000 | -20.2% | 3,000 | -15.0% | 0.04% | -16.0% |
| Q1 2019 | $302,000 | +39.8% | 3,531 | -64.4% | 0.05% | -13.8% |
| Q4 2016 | $216,000 | – | 9,908 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |